Biogen Inc. Files 8-K on Shareholder Votes and Financials
Ticker: BIIB · Form: 8-K · Filed: Jun 23, 2025 · CIK: 875045
| Field | Detail |
|---|---|
| Company | Biogen Inc. (BIIB) |
| Form Type | 8-K |
| Filed Date | Jun 23, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, financial-reporting, sec-filing
Related Tickers: BIIB
TL;DR
Biogen filed an 8-K on June 23rd about shareholder votes and financials from June 17th.
AI Summary
Biogen Inc. filed an 8-K on June 23, 2025, reporting on events that occurred on June 17, 2025. The filing primarily concerns the submission of matters to a vote of security holders and includes financial statements and exhibits. Biogen Inc. is incorporated in Delaware and headquartered in Cambridge, Massachusetts.
Why It Matters
This filing provides updates on important corporate actions and financial reporting for Biogen Inc., which can influence investor decisions.
Risk Assessment
Risk Level: low — This is a routine filing for corporate actions and financial reporting, not indicating immediate operational or financial distress.
Key Numbers
- 0-19311 — SEC File Number (Identifies Biogen's filing with the SEC.)
- 33-0112644 — IRS Employer Identification No. (Biogen's tax identification number.)
Key Players & Entities
- BIOGEN INC. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- 225 Binney Street, Cambridge, Massachusetts 02142 (address) — Principal executive offices
- June 17, 2025 (date) — Date of earliest event reported
- June 23, 2025 (date) — Date of report
FAQ
What specific matters were submitted to a vote of Biogen Inc.'s security holders?
The filing indicates that matters were submitted to a vote of security holders, but the specific details of these matters are not provided in the excerpt.
What is the significance of the 'Financial Statements and Exhibits' mentioned in the filing?
This indicates that the filing includes important financial information and supporting documents for Biogen Inc., which are crucial for investors to assess the company's performance.
When did Biogen Inc. change its name from Biogen Idec Inc.?
Biogen Inc. changed its name from Biogen Idec Inc. on April 27, 2007.
What is Biogen Inc.'s fiscal year end?
Biogen Inc.'s fiscal year ends on December 31.
What is the SIC code for Biogen Inc.?
The Standard Industrial Classification (SIC) code for Biogen Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 23, 2025 regarding BIOGEN INC. (BIIB).